Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CABLES1
REST API REST API
Homo sapiens
CABLES1 is differentially expressed in 174 experiments: 81 organism parts: mammary gland, accumbens, ... (79 more);, 65 disease states: normal, benign prostatic hyperplasia, ... (63 more);, 63 cell types 317 cell lines 23 compound treatments and 52 other conditions.
Synonyms FLJ35924, HsT2563
Orthologs F1NSZ8_CHICK (Gallus gallus)   Cables1 (Rattus norvegicus)   F1MZY0_BOVIN (Bos taurus)   Cables1 (Mus musculus)   F6UPB9_CIOIN (Ciona intestinalis)   cables1 (Danio rerio)   CG6191 (Drosophila melanogaster)   cables1 (Xenopus laevis)   CABLES1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, cyclin-dependent protein kinase regulator activity, protein binding, cytoplasm, blood coagulation, regulation of cell cycle, nucleus, regulation of cell division, nervous system development
InterPro Term Cyclin_N, Cdk5/c-Abl_linker_Cables
UniProt Accession Q8TDN4, A7K6Y5, B4DK60
Search EB-eye ENSG00000134508
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-803, E-GEOD-6573, E-GEOD-18105, E-MTAB-69, ... (11 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-19639, E-GEOD-3202, E-GEOD-19466, ... (26 experiments)

Factor Value U/D Experiments
MCF-7
3
 E-GEOD-5823, E-GEOD-19639, E-GEOD-20081
LNCaP
2
 E-GEOD-14990, E-GEOD-14464
A549
2
 E-GEOD-6013, E-GEOD-3202
CCRFCEM
2
 E-MTAB-37, E-GEOD-24147
HL-60
2
 E-GEOD-24147, E-MTAB-37
K562
2
 E-MTAB-37, E-GEOD-24147
311 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-4219, E-GEOD-13987, ... (29 experiments)

Factor Value U/D Experiments
centroblast
2
 E-TABM-702, E-GEOD-15271
induced pluripotent stem cell
2
 E-GEOD-18147, E-GEOD-18265
nucleus pulposus
1
 E-MEXP-2488
spermatid
1
 E-TABM-130
adipose stem cells derived from adult human donor
1
 E-GEOD-20033
CXCR4 negative
1
 E-GEOD-15893
57 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-1121, E-MEXP-2069, ... (32 experiments)

Factor Value U/D Experiments
pancreatic carcinoma
2
 E-MTAB-37, E-MEXP-1121
control
2
 E-GEOD-21912, E-GEOD-16363
chronic myelogenous leukemia
1
 E-MTAB-37
uterine fibroid
1
 E-GEOD-7307
FAB: M4 acute myeloid leukemia
1
 E-GEOD-12662
Kaposi's sarcoma
1
 E-MEXP-561
59 more value(s).


Compound treatment

studied in E-GEOD-5741, E-TABM-782, E-TABM-868, E-GEOD-5099, E-MEXP-1958, ... (17 experiments)

Factor Value U/D Experiments
none
3
4
 E-TABM-782, E-GEOD-20719, E-MEXP-1958, E-GEOD-5741, E-MEXP-1230, ... (7 experiments)
baseline sevoflurane
1
 E-GEOD-4386
cigarette smoke
1
 E-MEXP-1512
estradiol
1
 E-GEOD-20081
CNOT7+CNOT8
1
1
 E-MEXP-2218
TTA
1
 E-MEXP-2590
17 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
 E-GEOD-19519
thapsigargin
1
 E-GEOD-19519
tunicamycin
1
1
 E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19246, E-GEOD-21374, E-GEOD-21589, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-22541, E-GEOD-22148

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (8 experiments)

Genotype
studied in E-TABM-763, E-TABM-1029, E-GEOD-12662, E-GEOD-17476, E-TABM-868, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-GEOD-9764, E-GEOD-10315, E-MEXP-2146

Histology
studied in E-TABM-234, E-TABM-276

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (19 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-12662

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-MEXP-1412, E-GEOD-17636, E-MEXP-1403

Population
studied in E-MTAB-197, E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19246, E-GEOD-20037

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-1643, E-GEOD-22541, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-15799

Tumor grading
studied in E-GEOD-4290, E-GEOD-22541

Processing time: 0.506 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM